Bibliography

Found 21 results

Filters: Keyword is Inflammation [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Sattler FR, He J, Letendre S, Wilson C, Sanders C, Heaton R, Ellis R, Franklin D, Aldrovandi G, Marra CM, et al. Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation. J Acquir Immune Defic Syndr. 2015 ;68(3):281-8.

Vartak-Sharma N, Gelman BB, Joshi C, Borgamann K, Ghorpade A. Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression. J Biol Chem. 2014 ;289(28):19599-612.

C

Cosenza-Nashat MA, Bauman A, Zhao ML, Morgello S, Suh H-S, Lee SC. Cannabinoid Receptor Expression in HIV Encephalitis and HIV-associated Neuropathologic Comorbidities. Neuropathology and Applied Neurobiology [Internet]. 2011 ;37(5):464-483. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21450051

Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS, Heaton R, Samuels DC, Franklin DR, Rosario-Cookson D, et al. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection. Mol Neurobiol. 2019 ;56(5):3808-3818.

Cassol E, Misra V, Dutta A, Morgello S, Gabuzda D. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS [Internet]. 2014 ;28(11):1579-1591. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24752083

Wüthrich C, Kesari S, Kim W-K, Williams KC, Gelman R, Elmeric D, De Girolami U, Joseph J, Hedley-Whyte T, Koralnik IJ. Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells. Journal of Neurovirology [Internet]. 2006 ;12(2):116-28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16798673

Sundermann EE, Erlandson KM, Pope CN, Rubtsova A, Montoya J, Moore AA, Marzolini C, O'Brien KK, Pahwa S, Payne BAI, et al. Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging. AIDS Res Hum Retroviruses. 2019 ;35(11-12):985-998.

E

Suh H-S, Lo Y, Choi N, Letendre S, Lee SC. Evidence of the innate antiviral and neuroprotective properties of progranulin. PLoS One. 2014 ;9(5):e98184.

H

Gill AJ, Kovacsics CE, Cross SA, Vance PJ, Kolson LL, Jordan-Sciutto KL, Gelman BB, Kolson DL. Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. J Clin Invest. 2014 ;124(10):4459-72.

Singer EJ, Valdes-Sueiras M, Commins D, Yong WH, Carlson M. HIV Stroke Risk: Evidence and Implications. Therapeutic Advances in Chronic Disease [Internet]. 2013 ;4(2):61-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=23556125

Prevedel L, Morocho C, Bennett MVL, Eugenin EA. HIV-Associated Cardiovascular Disease: Role of Connexin 43. Am J Pathol. 2017 ;187(9):1960-1970.

Guha D, Wagner MCE, Ayyavoo V. Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury. J Neuroinflammation. 2018 ;15(1):126.

I

Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre S, Notestine RJ, Taylor MJ, Theilmann RJ, Julaton MD, Croteau D, et al. Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol. 2013 ;19(4):393-401.

J

Williams DW, Anastos K, Morgello S, Berman JW. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol [Internet]. 2015 ;97(2):401-12. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25420915

M

Swinton MK, Carson A, Telese F, Sanchez AB, Soontornniyomkij B, Rad L, Batki I, Quintanilla B, Pérez-Santiago J, Achim CL, et al. Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia. Neurobiol Dis. 2019 ;130:104502.

N

Kim WJ, Zekas E, Lodge R, Susan-Resiga D, Marcinkiewicz E, Essalmani R, Mihara K, Ramachandran R, Asahchop E, Gelman B, et al. Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder. Mol Cell Biol. 2015 ;35(21):3684-700.

P

Cassol E, Misra V, Holman AG, Kamat A, Morgello S, Gabuzda D. Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors. BMC Infectious Diseases [Internet]. 2013 ;13:203. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=23641933

Guha D, Lorenz DR, Misra V, Chettimada S, Morgello S, Gabuzda D. Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment. J Neuroinflammation. 2019 ;16(1):254.

S

Chaudhuri AD, Yang B, Gendelman HE, Persidsky Y, Kanmogne GD. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood [Internet]. 2008 ;111:2062-72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18003888

V

Robinson-Papp J, Nmashie A, Pedowitz E, Benn EKT, George MCatherine, Sharma S, Murray J, Machac J, Heiba S, Mehandru S, et al. Vagal dysfunction and small intestinal bacterial overgrowth: novel pathways to chronic inflammation in HIV. AIDS. 2018 ;32(9):1147-1156.

Guha D, Misra V, Yin J, Horiguchi M, Uno H, Gabuzda D. Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy. AIDS. 2023 ;37(14):2137-2147.